Volitionrx (VNRX) Equity Average (2012 - 2025)

Volitionrx (VNRX) has 10 years of Equity Average data on file, last reported at -$35.8 million in Q4 2025.

• For the quarter ending Q4 2025, Equity Average fell 50.46% year-over-year to -$35.8 million; the trailing twelve-month figure through Dec 2025 stood at -$35.8 million (down 50.46% YoY), and the FY2025 full-year result was -$30.3 million, down 79.95% from the prior year.
• Equity Average for Q4 2025 stood at -$35.8 million, down from -$34.5 million in the prior quarter.
• Across five years, Equity Average topped out at $28.9 million in Q2 2021 and bottomed at -$35.8 million in Q4 2025.
• The 5-year median for Equity Average is -$1.6 million (2022), against an average of -$4.6 million.
• The widest annual swing landed in 2021, when Equity Average soared 107.52%; it then tumbled 3927.22% in 2023.
• A 5-year view of Equity Average shows it stood at $19.5 million in 2021, then slumped by 100.74% to -$143567.0 in 2022, then sank by 3927.22% to -$5.8 million in 2023, then tumbled by 311.19% to -$23.8 million in 2024, then tumbled by 50.46% to -$35.8 million in 2025.
• The last three Equity Average figures came in at -$35.8 million (Q4 2025), -$34.5 million (Q3 2025), and -$31.1 million (Q2 2025), per Business Quant data.

Peer Comparison